C07D 223/16
Benzazepines
Official title: Benzazepines; Hydrogenated benzazepines
C07D223/16 (Benzazepines) appears on 621 US grants and 520 published applications in this corpus.
Search patents in C07D- Granted patents
- 621
- Published applications
- 520
- Assignees
- 293
- Inventors
- 1,761
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 6 | 0 |
| 1978 | 9 | 0 |
| 1979 | 7 | 0 |
| 1980 | 8 | 0 |
| 1981 | 11 | 0 |
| 1982 | 11 | 0 |
| 1983 | 7 | 0 |
| 1984 | 11 | 0 |
| 1985 | 7 | 0 |
| 1986 | 6 | 0 |
| 1987 | 9 | 0 |
| 1988 | 11 | 0 |
| 1989 | 7 | 0 |
| 1990 | 10 | 0 |
| 1991 | 15 | 0 |
| 1992 | 7 | 0 |
| 1993 | 15 | 0 |
| 1994 | 11 | 0 |
| 1995 | 12 | 0 |
| 1996 | 17 | 0 |
| 1997 | 23 | 0 |
| 1998 | 12 | 0 |
| 1999 | 12 | 0 |
| 2000 | 12 | 0 |
| 2001 | 5 | 1 |
| 2002 | 10 | 9 |
| 2003 | 10 | 13 |
| 2004 | 6 | 21 |
| 2005 | 9 | 36 |
| 2006 | 15 | 29 |
| 2007 | 20 | 41 |
| 2008 | 20 | 33 |
| 2009 | 12 | 36 |
| 2010 | 15 | 34 |
| 2011 | 20 | 20 |
| 2012 | 34 | 17 |
| 2013 | 23 | 30 |
| 2014 | 24 | 33 |
| 2015 | 28 | 20 |
| 2016 | 17 | 21 |
| 2017 | 16 | 15 |
| 2018 | 8 | 13 |
| 2019 | 23 | 19 |
| 2020 | 10 | 13 |
| 2021 | 7 | 12 |
| 2022 | 5 | 12 |
| 2023 | 6 | 13 |
| 2024 | 2 | 11 |
| 2025 | 6 | 16 |
| 2026 | 10 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Benzoazepine compound, and composition and use thereof15 Sep 2026US 12,735,398 B2Shanghaitech University
- Benzonitric heterocyclic compound, preparation method therefor and use thereof18 Aug 2026US 12,709,600 B2Shanghai Institute of Pharmaceutical Industry
- Tetrahydroisoquinoline compound as potassium channel modulator and preparation and application thereof11 Aug 2026US 12,703,687 B2Shanghai Zhimeng Biopharma, Inc.
- Benzazepine compounds, preparation method therefor and pharmaceutical use thereof23 Jun 2026US 12,662,497 B2Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- Covalent, chemogenetic activators for k2p potassium channels and uses thereof9 Apr 2026US 2026/0098008 A1The Regents of the University of California
- Novel b0at1 inhibitor1 Jan 2026US 2026/0001849 A1Mitsubishi Tanabe Pharma Corporation
- Azepine fused ring compound as ripk1 inhibitor and use thereof4 Dec 2025US 2025/0368633 A1Artivila Biopharma
- Sarm1 modulators, preparations, and uses thereof16 Oct 2025US 2025/0320184 A1Sironax Ltd.
- Haloalkyl sulfonanilide compound and herbicide containing the same18 Sep 2025US 2025/0289788 A1Sds Biotech K. K.
Most cited
By later US patents
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Condensed heterocyclic compounds154US 5,037,825 AHoffmann-La Roche Inc. · 1991
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids114US 4,410,520 ACiba-Geigy Corporation · 1983
- Benzo-fused lactams that promote the release of growth hormone109US 5,206,235 AMerck & Co., Inc. · 1993